Outpatient CAR-T Therapy Revolutionizing Cancer Treatment
US Pharm. 2025;50(4):HS-2-HS-6 ABSTRACT: Chimeric antigen receptor T-cell (CAR-T) therapy represents a groundbreaking advancement in personalized immunotherapy, offering new hope to patients with refractory cancer. Traditionally administered in inpatient …